QI
SCLN

Quotient Investors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Quotient Investors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,391
Closed -$96K – 248
2015
Q4 		$96K Sell
10,391
-20,516
-66% -$172K 0.04% 209
2015
Q3 		$214K Sell
30,907
-46,493
-60% -$398K 0.05% 189
2015
Q2 		$760K Buy
77,400
+9,000
+13% +$82K 0.1% 140
2015
Q1 		$606K Buy
68,400
+42,100
+160% +$335K 0.08% 159
2014
Q4 		$230K Hold
26,300
– – 0.05% 218
2014
Q3 		$181K Buy
+26,300
New +$158K 0.04% 215

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quotient Investors's SCLN Position: Q1 2016 in Review

Quotient Investors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2016, closing a stake of 10,391 shares — an estimated $96K sold.

Quotient Investors first reported a position in SCLN in Q3 2014 and held it in 6 quarters. The position peaked at $760K in Q2 2015. 142 funds tracked by Wall St. Rank hold SCLN as of Q1 2016.

  • Quotient Investors reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Quotient Investors sold 10,391 Sciclone Pharmaceuticals Inc shares in Q1 2016, an estimated $96K.
  • Quotient Investors first reported a position in Sciclone Pharmaceuticals Inc in Q3 2014 and held it in 6 quarters.
  • Quotient Investors's Sciclone Pharmaceuticals Inc position peaked at $760K in Q2 2015.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2016.

Based on Quotient Investors's 13F filing for Q1 2016, filed 14 Apr 2016.